FLURAZEPAM DIN 00521698
Health Canada record
| Active ingredient(s) | FLURAZEPAM HYDROCHLORIDE 15 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| Class | Human |
| ATC | N05CD01 FLURAZEPAM |
| Original market date | 31-Dec-1982 |
| Current status date | 17-Dec-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
AA Pharma Inc. — licence 101851, currently licensed, last inspection rating C (2023-05-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLURAZEPAM HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00521701 | FLURAZEPAM | AA PHARMA INC | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Marketed |
| 02248126 | BIO-FLURAZEPAM | BIOMED PHARMA | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 02248127 | BIO-FLURAZEPAM | BIOMED PHARMA | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 00012696 | DALMANE | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 00012718 | DALMANE | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 00578479 | FLURAZEPAM 15 | PRO DOC LIMITEE | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 02232656 | FLURAZEPAM 15MG CAPSULE | LABORATOIRES CONFAB INC | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Pre Market |
| 00578487 | FLURAZEPAM 30 | PRO DOC LIMITEE | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 02232657 | FLURAZEPAM 30MG CAPSULE | LABORATOIRES CONFAB INC | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Pre Market |
| 00496545 | NOVO-FLUPAM CAP 15MG | NOVOPHARM LIMITED | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 00496553 | NOVO-FLUPAM CAP 30MG | NOVOPHARM LIMITED | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 00667102 | PMS-FLURAZEPAM CAP 15MG | PHARMASCIENCE INC | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 00667099 | PMS-FLURAZEPAM CAP 30MG | PHARMASCIENCE INC | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 02241281 | RIVA-FLURAZEPAM 15MG CAPSULES | LABORATOIRE RIVA INC. | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 02241282 | RIVA-FLURAZEPAM 30MG CAPSULES | LABORATOIRE RIVA INC. | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 00414220 | SOM-PAM | BIOMED PHARMA | Capsule | FLURAZEPAM HYDROCHLORIDE 15 MG | Dormant |
| 00414239 | SOM-PAM | BIOMED PHARMA | Capsule | FLURAZEPAM HYDROCHLORIDE 30 MG | Dormant |
| 00483826 | SOMNOL 15MG | AXXESS PHARMA INC. | Tablet | FLURAZEPAM HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 00483818 | SOMNOL 30MG | AXXESS PHARMA INC. | Tablet | FLURAZEPAM HYDROCHLORIDE 30 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16868 | 2015-05-05 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBERS |
International API supply for FLURAZEPAM HYDROCHLORIDE
1 active FDA Drug Master Files.
Request a quote for FLURAZEPAM